| Diabetes Treatment and Management | Lifetime | 268 | US 109 | 98.91 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 323 | US 149 | 98.82 |
| Cardiovascular Function and Risk Factors | Lifetime | 804 | US 410 | 98.65 |
| Diabetes Management and Research | Lifetime | 469 | US 219 | 98.35 |
| Diabetes Management and Education | Lifetime | 255 | US 133 | 97.41 |
| Heart Failure Treatment and Management | Lifetime | 653 | US 305 | 97.69 |
| Metabolism, Diabetes, and Cancer | Lifetime | 991 | US 413 | 96.76 |
| Cardiovascular Health and Risk Factors | Lifetime | 384 | US 222 | 95.27 |
| Chronic Disease Management Strategies | Lifetime | 827 | US 271 | 95.56 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | Lifetime | 771 | US 336 | 92.34 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 499 | US 127 | 90.90 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 16 | US 5 | 99.50 |
| Diabetes Management and Research | 2021-2025 | 26 | US 20 | 99.47 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 62 | US 35 | 99.57 |
| Diabetes Treatment and Management | 2021-2025 | 39 | US 26 | 99.61 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 42 | US 21 | 98.69 |
| Heart Failure Treatment and Management | 2021-2025 | 111 | US 47 | 98.74 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 128 | US 52 | 97.44 |
| Heart Rate Variability and Autonomic Control | 2021-2025 | 133 | US 42 | 96.01 |
| Gestational Diabetes Research and Management | 2021-2025 | 110 | US 26 | 96.40 |
| Pancreatic function and diabetes | 2021-2025 | 229 | US 97 | 95.75 |
| Diabetes Management and Education | 2021-2025 | 176 | US 68 | 91.59 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 334 | US 91 | 89.91 |
| Pregnancy and preeclampsia studies | 2021-2025 | 596 | US 164 | 92.71 |
| Diabetes and associated disorders | 2021-2025 | 395 | US 151 | 92.19 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 227 | US 114 | 91.01 |
| Birth, Development, and Health | 2021-2025 | 778 | US 269 | 90.99 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | 2021-2025 | 124 | US 57 | 88.62 |
| Chronic Disease Management Strategies | 2021-2025 | 729 | US 134 | 86.13 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 517 | US 105 | 83.28 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 972 | US 268 | 85.16 |
| Bariatric Surgery and Outcomes | 2021-2025 | 821 | US 236 | 82.80 |
| Cardiovascular Syncope and Autonomic Disorders | 2021-2025 | 418 | US 132 | 78.33 |
| Cardiovascular Issues in Pregnancy | 2021-2025 | 879 | US 302 | 74.44 |
| GDF15 and Related Biomarkers | 2021-2025 | 730 | US 182 | 49.61 |
